Gentamicin Ophthalmic Solution Recalled for Crystalline Particulate Matter
H J Harkins Company is recalling Gentamicin Ophthalmic Solution due to crystalline particles found during clarity testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves particulate matter in an ophthalmic solution without reported injuries or illnesses, fitting the criteria for a moderate severity recall.
Plain-English summary
H J Harkins Company Inc dba Pharma Pac is recalling 84 bottles of Gentamicin Ophthalmic Solution, 5 mL. The product is identified by NDC 52959-0103-00 and was distributed nationwide in the USA and Puerto Rico.
The recall was initiated because crystalline particles were noticed by the manufacturer during 24-month clarity testing. The affected lots are GNT01AK with an expiration date of 02/19 and GNT07AK with an expiration date of 3/20.
Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for instructions on how to dispose of the medication or obtain a replacement.
The recalled product
- Product
- GENTAMICIN OPTH-SOL 5ml Compare: Garamycin. 5-mL plastic dropper bottle, Mfg: AKORN 17478-0283-10. NDC 52959-0103-00
- Manufacturer
- H J Harkins Company Inc dba Pharma Pac
- Category
- Drug — Ophthalmic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # GNT01AK
- Exp. 02/19 & GNT07AK
- Exp. 3/20
Distribution
Related recalls
Same manufacturer · H J Harkins Company Inc dba Pharma Pac
See all →- ModerateFDA Recalls Acetaminophen and Codeine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2020-04-22
- HighAcetaminophen Tablets Recalled Due to Foreign Tablet Contamination
FDA (Drugs) · 2020-03-18
- SevereRanitidine Tablets Recalled Due to NDMA Impurity Detection
FDA (Drugs) · 2020-01-29
- ModeratePharma Pac Recalls Neomycin Ophthalmic Ointment for Quality Control Issues
FDA (Drugs) · 2019-08-07
- SevereDiphenhydramine Liquid Recalled for Potential Microbial Contamination
FDA (Drugs) · 2019-07-03
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26